During the past decade, Emory University Health Science Research Building conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Emory University Health Science Research Building" are "Crohn Disease" (2 trials). Many other conditions were trialed in "Emory University Health Science Research Building" in a lesser frequency.

Most popular intervention types in "Emory University Health Science Research Building" are "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Emory University Health Science Research Building" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Emory University Health Science Research Building". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Emory University Health Science Research Building, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Emory University Health Science Research Building, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".